The SENSE Study (Sleep and Education: learning New Skills Early): a community cognitive-behavioural therapy and mindfulness-based sleep intervention to prevent depression and improve cardiac health in adolescence by Joanna M. Waloszek et al.
STUDY PROTOCOL Open Access
The SENSE Study (Sleep and Education:
learning New Skills Early): a community
cognitive-behavioural therapy and
mindfulness-based sleep intervention to
prevent depression and improve cardiac
health in adolescence
Joanna M. Waloszek1, Orli Schwartz1, Julian G. Simmons1, Matthew Blake1, Laura Blake1, Greg Murray2,
Monika Raniti1, Ronald E. Dahl3, Neil O’Brien-Simpson5, Paul Dudgeon1, John Trinder1 and Nicholas B. Allen1,4*
Abstract
Background: Sleep problems are a major risk factor for the emergence of depression in adolescence. The aim of
this study was to test whether an intervention for improving sleep habits could prevent the emergence of depression,
and improve well-being and cardiovascular indices amongst at-risk adolescents.
Methods/Design: A longitudinal randomised controlled trial (RCT) is being conducted across Victorian Secondary
Schools in Melbourne, Australia. Adolescents (aged 12–17 years) were defined as at-risk for depression if they
reported high levels of anxiety and sleep problems on in-school screening questionnaires and had no prior
history of depression (assessed by clinical diagnostic interview). Eligible participants were randomised into either
a sleep improvement intervention (based on cognitive behavioral and mindfulness principles) or an active control
condition teaching study skills. Both programs consisted of seven 90 minute-long sessions over seven weeks. All
participants were required to complete a battery of mood and sleep questionnaires, seven-days of actigraphy, and
sleep diary entry at pre- and post-intervention. Participants also completed a cardiovascular assessment and two days
of saliva collection at pre-intervention. Participants will repeat all assessments at two-year follow up (ongoing).
Discussion: This will be the first efficacy trial of a selective group-based sleep intervention for the prevention of
depression in an adolescent community sample. If effective, the program could be disseminated in schools and
greatly improve health outcomes for anxious adolescents.
Trial registration: Australian New Zealand Clinical Trials Registry ACTRN12612001177842. Date of Registration:
06-Nov-2012.
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Background
Adolescent depression is both common and harmful, with
an estimated 15–20 % of adolescents experiencing clinical
depression [1]. Depression is strongly associated with dis-
turbed sleep [2], a relationship that is particularly marked
in adolescence [3], and there is accumulating evidence
that disturbed sleep can play a precipitating role in the
onset of depression and other problems during adoles-
cence [4]. The likelihood that sleep disturbance plays a
critical etiological role in adolescent depression suggests
that sleep improvement might decrease risk for the devel-
opment of depression. Moreover, improved sleep may
benefit other aspects of health, including cardiovascular
health [5]. There is a complex relationship between de-
pression, sleep and cardiovascular disease (CVD) across
the lifespan [6], suggesting that early intervention for sleep
may impact on a mechanism jointly associated with risk
for CVD and depression. The potential public health ben-
efits of effective early intervention for sleep problems are
therefore substantial, and a treatment trial is warranted.
Depression, anxiety and sleep disturbance in adolescence
In adolescence, there is a significant rise in depression
incidence [1] and increased risk for a deterioration in
the quantity and/or quality of sleep [7]. Factors that
appear to contribute to adolescent vulnerabilities to
sleep problems include maturational changes in both the
homeostatic and circadian regulation of sleep [8, 9], less
parental control over bedtime, as well as the develop-
ment of cultural and social interests and obligations
such as homework, hobbies and use of electronic media
in the evening that interfere with bedtime. Importantly,
these factors often appear to interact with each other
contributing to late-night and erratic sleep onset times,
and these interact with (relatively early) school starting
times to reduce sleep duration [10]. Research has also
shown that anxious youths may be at particular risk for
sleeping difficulties [11–15]. Importantly, anxiety often
precedes the emergence of depressive disorders and the
onset of insomnia, whereas episodes of depression follow
bouts of insomnia [16], suggesting that sleep disturbance
might serve as a mediating link between anxiety and
depression.
Disturbed sleep and depression
Sleep problems are cross-sectionally associated with ado-
lescent depression [17], and recent longitudinal studies
have demonstrated that sleep problems are also prospect-
ively associated with depression in adolescents [18–21].
There is also emerging evidence that manipulations of ad-
olescents’ sleep can modify psychological factors, includ-
ing depressive symptoms [22, 23]. These findings suggest
that targeting sleep problems in early-to-mid adolescents
who have high levels of anxiety and concomitant sleep
problems may constitute an effective targeted prevention
approach to depression in this age group.
Depression, sleep disturbance and heart disease
There is strong evidence linking poor sleep and heart
disease [24, 25], and in young people, poor sleep quality
and sleep disorders have been associated with risk fac-
tors for later cardiac disease [26–31]. Furthermore, treat-
ment of youth sleep disorders has been associated with a
reduction in cardiovascular disturbances [29].
The relationship between depressive disorders and
cardiac disease is also well-established [32], although the
mechanisms underlying the association are not yet well
understood [33]. Depression is a significant predictor of
the onset of coronary artery disease [34] as well as of
cardiac mortality in patients with coronary heart disease
[33, 35]. Although case level CVD in those vulnerable to
depression will typically emerge in later life, there are
now strong indicators that, during adolescence, depres-
sion is associated with cardiovascular abnormalities that
may be early indicators of compromised cardiovascular
health [36–41]. Improving the quality of sleep in adoles-
cents who are at risk for depression may therefore
present a viable early intervention that improves both
cardiovascular and mental health. To date no such study
has been undertaken.
Mechanisms underling the association between
depression and CVD
A number of mechanisms have been identified as poten-
tial links between depression and CVD, and may also
constitute early indicators of the development of CVD.
These include disturbance in autonomic cardiac control,
vascular endothelial dysfunction in coronary arteries,
and immune system activation (see [32], for a recent
comprehensive review). Many markers of systemic in-
flammation that have been found to be elevated in de-
pressed persons, such as IL-6, tumor necrosis factor-α
(TNF-α), and C-reactive protein (CRP) [42] have also
been shown to be predictive of CVD [43]. Although
there is no definitive agreement as to which of these
mechanisms might be most critical to the link between
CVD and depression, they each enjoy preliminary support.
Importantly, no studies have comprehensively charac-
terised these aspects of cardiac functioning in young
people at risk for depression; nor has any study investi-
gated whether a sleep intervention might modify such risk
factors. The proposed study will address both of these
critical issues.
Study aims and main objectives
The aim of the SENSE (Sleep and Education: learning New
Skills Early) Study is to determine the preventative effect of
a sleep improvement intervention on the emergence of
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depression in an at-risk adolescent population. The project
also provides the opportunity to test a potential nexus
between sleep, depression and CVD, and to measure the
intervention’s effects on early indices of risk for CVD.
Specifically it is hypothesized that, relative to an active
study skills control intervention (Study SENSE):
1. A brief sleep intervention (Sleep SENSE) will improve
both subjective and objective indices of sleep quality
in a sample of at risk adolescents, and that this
improvement will persist at a two-year follow-up.
2. The sleep intervention will decrease reports of
anxiety and mood symptoms immediately after the
intervention and prevent the onset of case-level
depression over a two-year follow-up period in a
sample of at risk adolescents.
3. The sleep intervention will improve indices of
cardiovascular health at two-year follow-up. In
particular, levels of IL-1α, IL-1β, TNFα, IL-6, and
C-reactive protein will decrease and endothelial
function will improve.
4. Benefits to both mental and cardiovascular health
will be mediated by the measured improvements in
sleep that result from the sleep intervention.
Methods
Design
The project is a longitudinal parallel randomised con-
trolled trial (RCT) in which the experimental group took
part in a CBT/mindfulness-based sleep intervention
(Sleep SENSE) and the active control group took part in
a study skills educational program (Study SENSE). The
control intervention was chosen to have strong face
validity as a well-being and/or performance enhancing
intervention for adolescents, and to entail similar levels
of effort and engagement with interventionists as did the
Sleep SENSE intervention. Participants were recruited
via a school-based screening to identify students from
the general community with high levels of anxiety and
sleeping difficulties. Participants underwent assessments
of sleep and psychopathology before and immediately
after the intervention phase, and will again at the two-year
follow-up. Cardiovascular health was assessed before the
intervention and will be re-assessed at the two-year
follow-up. As adolescent sleep is strongly affected by
school schedules [44], the intervention and sleep assess-
ments were timetabled during school term time.
Ethics, consent and permissions
Participants were recruited from secondary schools in the
Melbourne Metropolitan Area, Australia. Pre/post-inter-
vention data collection was conducted in the Melbourne
School of Psychological Sciences at the University of
Melbourne, Australia. Interventions were also held at the
University, except for one group that was held at the par-
ticipants’ school. The study and all procedures, including
data management and participant confidentiality, were
approved by the University of Melbourne Human Re-
search Ethics Committee (HREC#1237312), the Depart-
ment of Education and Early Childhood Development
(DEECD) (2012_001659), and the Catholic Education
Office Melbourne (CEOM) (GE12/000091819), and com-
plied with National Health and Medical Research Council
guidelines. All participants and their guardians gave writ-
ten informed consent before participating in the study.
The SENSE Study is registered in the Australia and New
Zealand Clinical Trials Registry (ACTRN12612001177842)
and funding for the project was received through the
Australian National Health and Medical Research Council
(APP1027076) (Additional files 1 and 2).
Procedure
The SENSE Study has five data collection ‘Phases’ in
addition to the Intervention itself. Details of the phases,
recruitment process and participant numbers at each
phase can be found in Fig. 1. Phases 1–4 (screening-
post-intervention assessments) have been completed and
Phase 5 (2-year follow up assessments) is ongoing.
Participants were reimbursed for their time and travel
expenses with a department store voucher for each
assessment during Phases 2–5.
Participant recruitment
Participants were recruited using a two-stage procedure,
consisting of an in-school screening followed by a diag-
nostic interview for those meeting screening criteria, to
identify students with high levels of anxiety and sleeping
difficulties but without a history of depressive disorder.
Selected adolescents were then invited to take part in
the trial (Phases 2–5 of the study).
Schools were selected and approached based on geo-
graphical proximity (within 35 km) to the University of
Melbourne, where assessments would take place. Schools
were contacted via letters or emails describing the study
in detail. Schools were offered information booklets and
tailored presentations on adolescent wellbeing to increase
interest in the study. Schools who did not wish to partici-
pate in the study indicated they did not have enough time
due to a full curriculum, were already participating in
other research studies (i.e., decline) or the school coordin-
ator was not contactable (i.e., passive decline).
All students in Years 7–10 were invited to participate
in the study; however the school coordinator determined
which classes would participate, based on student time
commitments, relevance to the teaching curriculum and
staff limitations. Students who provided written parental
consent (hardcopy or online) were asked to attend the
screening assessment session in a designated teacher-
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supervised classroom during school time. Researchers ex-
plained the study via standardised instructions and stu-
dents who wished to continue were asked to complete the
screening questionnaire pack (see Table 1 for details of
measures). The questionnaires took approximately 20 min
to complete.
Inclusion & exclusion criteria
Participants were required to have an adequate compre-
hension of English written and spoken language to partici-
pate in the study. Participants whose ratings on the
screening questionnaire indicated high anxiety on the
Spence Children’s Anxiety Scale ([SCAS], i.e. a Total
Score >32 and >38 for males and females respectively)
[45], as well as the likely presence of sleep problems as
identified by the Pittsburgh Sleep Quality Index ([PSQI],
i.e. a Global Score ≥ 5) [25], were invited to take part in a
face-to-face diagnostic interview based on DSM-IV-TR
criteria (the Kiddie Schedule for Affective Disorders and
Schizophrenia for School-Age Children-Present and Life-
time Version [K-SADS-PL]) with trained interviewers. The
interview was completed in the participant’s home or at
the University of Melbourne. Participants who scored
above the cut-off in the SCAS and PSQI in the screening
assessment, and who had never met criteria for Major
Depressive Disorder, as assessed using the K-SADS-PL,
were invited to participate in the pre-intervention baseline
assessments and group sessions.
Fig. 1 Flowchart of participation in each phase of the SENSE Study to date
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Baseline data collection
Participants who met inclusion criteria after the diagnos-
tic interview were asked to complete a number of assess-
ments prior to the group sessions. A week prior to the
group session, participants were sent a ‘Welcome Pack’
which included mood and sleep questionnaires, a sleep
diary, an Actiwatch and a saliva collection kit. Partici-
pants were asked to wear the Actiwatch and complete
the sleep diary for the seven days prior to the com-
mencement of the groups, as well as collect six saliva
samples over two days, complete the questionnaires and
return all materials to researchers at the first group ses-
sion. In cases where participants decided not to attend
the group sessions, a return post parcel was sent to par-
ticipants to retrieve any data.
Participants were also invited to participate in a car-
diovascular assessment conducted at the University of
Melbourne Sleep Laboratory. In order to control for
circadian variation in cardiovascular variables, the as-
sessment was conducted between the hours of 2:30 pm
and 6 pm. Participants were asked to reschedule if sick
and to refrain from consuming any food or drink other
than water for at least three hours prior to the assess-
ment, and from taking any medication in the 24 h prior
to the assessment. Upon arrival, participants were asked
questions about their demographic and medical history,
and their weight, height, percentage fat, waist and hip
circumference were measured. All cardiovascular mea-
surements were conducted in a seated position in a quiet
room with dim lighting and constant temperature of 22°
Celsius. After 5 min of quiet rest, three automatic mea-
surements of brachial blood pressure and heart rate were
taken, with a two-minute rest between each measurement.
Following these measures, continuous beat-to-beat blood
pressure and heart rate were monitored at rest for 15 min.
Finally, endothelial function following brachial occlusion
Table 1 Summary of measures administered at each data collection point
Category Measures Screening Pre-Intervention Post-Intervention Booster 1 & 2 Two-year
Follow-up
Psychopathology and Global Functioning SCAS x x x x x
CES-D x x x x x
K-SADS-PL x x x
YRBS-Sub x x x
CBCL-Ext x x x
CGAS x x x
LIFE-I x
Global Cognitive Style PSWQ-C x x x x
RSQ-Rumination x x x x
GSES x x x x
Sleep-Specific Cognitive Style SBS x x x x
DBAS-16 x x x x
PAS x x x x
Sleep PSQI x x x x x
rMEQ x
PDSS x x x x
Sleep Diary x x x
Actigraphy x x x
Cardiovascular Health Saliva samples x x
Blood Pressure x x
Heart rate x x
Endothelial dysfunction x x
Medical history questionnaire x x
CBCL-Ext Child Behaviour Checklist – Externalizing scale, CES-D Center for Epidemiologic Studies – Depression, CGAS Children’s Global Assessment of Functioning,
DBAS-16 Dysfunctional Beliefs about Sleep – 16 item version, GSES General Self-Efficacy Scale, K-SADS Schedule for Affective Disorders and Schizophrenia –
Children’s version, LIFE-I Longitudinal Interval Follow-up Evaluation Interview (Student work, Interpersonal Relations with Family, Depressive Disorders),
rMEQ reduced Morningness-Eveningness Questionnaire, PAS Pre-sleep Arousal Scale, PDSS Pediatric Daytime Sleepiness Scale, PSQI Pittsburg Sleep Quality
Index, PSWQ-C Penn State Worry Questionnaire - Children, RSQ-Rumination Response Scale Questionnaire – Rumination subscale, SBS Sleep Beliefs Scale,
SCAS Spence Children’s Anxiety Scale, YRBS-Sub Youth Risk Behavior Survey – Subscale use questions
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was also tested using standard procedures [46]. The car-
diovascular assessment took approximately 1.5 h.
Randomisation and blinding
After all Phase 1 assessments had been conducted (i.e., the
interview and questionnaires, sleep and cardiovascular
assessments), eligible participants who consented to partici-
pate in the intervention stage of the trial were randomly
allocated to receive either the sleep intervention (Sleep
SENSE) or the active control group (Study SENSE). A
blinded statistician randomised the eligible participants
stratified by gender, age and type of anxiety disorder at
baseline using a minimisation method available in the
MINIM program (SJW E, SJ D, P R. MINIM: minimisation
programme for allocating patients to treatment in clinical
trials. Unpublished document Department of Clinical Epi-
demiology, The London Hospital Medical College, London.
1990.) Participants and their guardians were made aware of
the content of the group sessions (i.e., study skills vs. sleep
skills) but not of the status of each group (i.e., intervention
versus control) or the expected outcome of the study. Re-
searchers conducting the post-intervention interviews were
also blinded to which group participants had completed.
Group sessions
As adolescent sleep is strongly affected by school sched-
ules, the intervention and pre-/post-intervention sleep
assessments were timetabled during school term time.
Participants who did not attend at least four sessions
were counted as ‘non-completers’.
Intervention group sessions
Sleep SENSE builds on the work of Dahl, Bootzin and
Harvey [47–51] and was successfully piloted among
Australian adolescent girls, demonstrating preliminary
effects on both subjective and objective measures of
sleep and self-reported anxiety [48]. Sleep SENSE is a
multi-component group program designed to improve
sleep by addressing barriers to sleep across the sleep-
wake cycle. It aims to improve sleep quality in the short
term and, via sustained behavior change, the long-term,
and is tailored to address the unique developmental chal-
lenges and opportunities of adolescence. Like evidence-
based adult treatments for insomnia, the intervention is
cognitive-behavioral in approach, incorporating sleep hy-
giene, stimulus control, cognitive-behavior therapy and
mindfulness-based therapy, and has a specific focus on
identifying barriers to change via motivational inter-
viewing. It involves 7 weekly 90-minute group sessions
supported by a range of psycho-educational materials and
at-home tasks. Psychologists or psychologists in training
facilitated interventions sessions. A summary of the
content covered in each session is displayed in Table 2.
Parents/care-givers were given information sheets about
the material covered in each session to ensure the adoles-
cent’s sleep improvement goals were integrated and sup-
ported by the family.
Control group sessions
Study SENSE was administered by a trained education
teacher and a co-facilitator for the same duration, and in
the same format as the Sleep SENSE intervention.
Components of the study skills group included writing per-
suasive essays, referencing, note taking and public speaking
(see Table 2 for a summary of the content in each session).
Post-intervention follow-up & booster sessions
Upon completion of the group sessions, all participants
were re-administered the mood and sleep questionnaire
pack first completed at pre-intervention, and were asked
to wear an Actiwatch and complete a sleep diary for the
following seven days. Assessment packs were distributed
in session seven in both the Sleep and Study SENSE
groups or it was sent to them at home if participants did
not attend the session. Participants also completed
another diagnostic interview, this time examining symp-
toms since the pre-intervention interview. The interview
was conducted by trained researchers over the phone or
face-to-face at the University of Melbourne and took an
average of 45 min to complete. All researchers conduct-
ing post-intervention interviews were blinded to the
group that the participants completed.
Following the group sessions, all participants were in-
vited to attend two ‘booster’ sessions, held at the University
of Melbourne at three and six months post-intervention.
In the booster sessions, components of the groups were re-
vised, any problems were discussed, and questions were
answered. No new content was introduced. At the end of
each booster session, participants were asked to complete
the same mood and sleep questionnaire pack given to them
at pre- and post-intervention. The questionnaire pack and
booster session notes were sent to participants who did
not attend the sessions with the option of sending back the
completed pack.
Two-year longitudinal follow-up
Participants will be contacted again two years after the
completion of their group sessions. This longitudinal
follow-up is ongoing. Participants will be asked to
complete a ‘Follow-up Pack’ that will include the same
contents as the pre-intervention ‘Welcome Pack’ (mood
and sleep questionnaires, saliva collection kit, and an
Actiwatch to wear and sleep diary to complete over
seven days). Participants will also be asked to take part
in a cardiovascular assessment and a clinical diagnostic
interview that will explore symptoms experienced since
the post-intervention interview. The Longitudinal Inter-
val Follow-up Evaluation Interview (LIFE-I) [52] will also
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be included in the follow-up interview. All researchers
conducting two-year follow-up interviews will be blinded
to the group that the participants completed.
Measures
Psychopathology measures
(a) Spence Children’s Anxiety Scale (SCAS) [53] -
The SCAS has been shown to be an effective
screening instrument for anxiety disorders in the
targeted age group. The SCAS is a brief self-report
test of anxiety symptoms broadly in line with the
dimensions of anxiety disorder proposed by the
DSM-IV. The scale assesses six domains of anxiety
including generalized anxiety, panic/agoraphobia,
social phobia, separation anxiety, obsessive-
compulsive disorder and physical injury fears. The
SCAS has normative data in the relevant age range
and has been shown to have good internal
consistency and temporal stability three months
apart among 12–15 year olds [54, 55]. This study
used the recommended total SCAS cut-offs
of >32 for males and >38 for females [45].
(b) Center for Epidemiologic Studies – Depression
Scale (CES-D) [56] - The CES-D is a reliable and
well-validated 20-item self-report questionnaire
measuring symptoms of depression during the past
week [56]. The CES-D has also been validated as a
reliable measure for the use in adolescents [57–59].
(c) Kiddie Schedule of Affective Disorders and
Schizophrenia Children's Version - Present and
Lifetime Version (K-SADS-PL) [60] – The KSADS-PL
is a semi-structured diagnostic interview widely used
for research of mood disorder in children and
adolescents. It has been shown to be a reliable and
valid measure of DSM-IV Axis 1 disorders in this
population [61]. The following modules were
administered: depression, mania, psychosis, panic
disorder, social phobia, specific phobia/agoraphobia,
generalised anxiety, obsessive-compulsive disorder,
separation anxiety, and post-traumatic stress
disorder. Interviews were conducted by trained
interviewers and audio recorded. Regular clinical
supervision was provided to all interviewers.
Approximately 20 % of interviews were double-
scored by another interviewer for inter-rater
reliability.
(d) The Youth Risk Behavior Survey (YRBS) [62] assesses
health-risk behaviors in youths. Thirty-two items
that assess tobacco, alcohol and other drug use were
administered.
(e) The Child Behavior Checklist, Youth Self Report
version (CBCL-YSR) [63] – The CBCL-YSR is a
widely used instrument assessing internalizing and
externalizing problem behaviors in young people
aged 11 to 18 years. The present study administered
the 45-item Externalizing subscale only.
(f ) Penn State Worry Questionnaire for Children
(PSWQ-C) - The PSWQ–C is a 14-item self-report
questionnaire designed to examine the generality,
excessiveness and uncontrollability of worry in
children and adolescents. It has excellent internal
consistency (α = .90) and temporal stability (r = .92)
among 12- to 18-year-olds [64].
(g) Rumination Responses Scale (RRS); subscale of the
Response Styles Questionnaire (RSQ-R) - The RRS
Table 2 Session outline of the sleep intervention and active control groups
Session Sleep Intervention Group (Sleep) SENSE Content Control Group (Study SENSE) Content
1 Introduction: education about sleep; identifying personal sleep goals; developing
motivation to change
Introduction: why good study skills and habits are
important for academic success.
2 Overcoming challenges to sleep: discuss good sleep hygiene and barriers to sleep,
learn stimulus control strategies; introduce mindfulness and mindfulness of the
breath practice.
Personal organization, time management and the
home study environment.
3 Establishing a regular sleep schedule: learn about circadian rhythms and guidelines for
keeping regular sleep schedule and limiting media use at bedtime; design a personal
sleep plan; mindfulness of the breath practice.
Active listening, learning, and note-taking
strategies.
4 Techniques for Managing Stress: learn about mindfulness, mindfulness qualities and
their benefits for sleep; practice mindful attention, mindfulness of the breath and the
body scan
Memory, memorization techniques, and different
ways of learning.
5 Focusing on the Positive: learn about the cognitive-behavioural model; learn to identify
and challenge unhelpful beliefs about sleep; practice savouring and switching and
mindfulness of the breath
Test-taking, critical reading and essay writing
strategies.
6 Managing worries: learn about the nature of worries and solvable versus unsolvable
problems; strategies for managing worries during the day (problem solving, scheduled
worry, worry box) and at night (mindfulness, savouring and switching); practice new
mindfulness strategies (the 3-minute breathing space & 'letting go' techniques).
Public speaking and speech writing
7 Your sleep into the future: review of sleep goals and progress; program review;
setback prevention; final mindfulness practice.
Review of Study SENSE program and problem
solving strategies.
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is a widely used and well-validated self-report
questionnaire that assesses the predisposition to
focus on or ruminate on depressed mood. The
RRS includes 22 items describing responses to
mood that are self-focused, symptom focused and
consequence-focused [65]. It has been shown to
have adequate psychometric properties with an
adolescent sample [66].
(h) General Self-Efficacy Scale (GSES) - The General Self-
Efficacy Scale is a 10-item self-report questionnaire
designed to assess a broad and stable sense of
personal competence to deal effectively with a
wide range of demanding or novel situations [67].
The GSES is widely used and has been shown to
have high reliability, stability and construct
validity [68].
(i) Longitudinal Interval Follow-up Evaluation Interview
(LIFE-I) [52] The LIFE-I is a semi-structured interview
used to assess the longitudinal course of participants’




(a) Sleep Diary is a widely used sleep questionnaire
that collects information on daily sleep onset,
morning awakening, and sleep quality.
(b) The Pittsburgh Sleep Quality Index (PSQI) – the
PSQI is a validated self-rated questionnaire used
to assess subjective sleep quality and disturbances
and the impact of poor sleep on functioning [69].
Adolescent sleep schedules are known to shift
dramatically across the week [70]. To explore this
shift, the first four questions of the PSQI were
altered to include a rating for sleep during the
week (i.e., Monday-Friday) as well as a separate
rating for weekend (i.e., Saturday-Sunday). This
study used the cut-off of a total PSQI of 5 and
above [25].
(c) The reduced Morningness-Eveningness Questionnaire
(rMEQ) - The rMEQ was developed from the
original Horne-Ostberg Morningness-Eveningness-
Questionnaire [71]. It consists of 5 items from the
original questionnaire (Items 1, 7, 10, 18, and 19),
which determine individual chronotype on a single
scale with minimum and maximum values from 4 to
25, where higher scores indicate a tendency towards
morningness. The conventional classification for
the scores are from 4–7 (Definitely-Evening), 8–11
(Moderately-Evening), 12–17 (Neither), 18–21
(Moderately-Morning) and 22–25 (Definitely-
Morning) [72]. Although this measure has not
been widely used for adolescents, it correlates
highly (r = 0.90) with the Morningness-
Eveningness Questionnaire [73] which has been
validated [74] and used in adolescent samples [75].
(d) Dysfunctional Belief and Attitudes about Sleep Scale –
16 (DBAS-16) - The DBAS-16 is an abbreviated form
of the original 30-item DBAS [76] and was designed
to assess dysfunctional sleep-related cognitions. The
factor structure of the brief form is similar to the
original 30-item version, with four factors reflecting
a) perceived consequences of insomnia, (b) worry/
helplessness about insomnia, (c) sleep expectations,
and (d) medication [77]. It has been shown to have
good internal consistency (α = 0.77 for clinical and
α = 0.79 for research samples) and temporal stability
(r = 0.83), and correlates with other self-report
measures of insomnia severity, anxiety and
depression [77].
(e) Pre-Sleep Arousal Scale (PAS) - The PAS is a 16-item
self-report questionnaire designed to measure
cognitive arousal (items 9–16; e.g., “worry about
falling asleep”) and somatic arousal (items 1-8; e.g.,
“cold feeling in your hands, feet or your body in
general”) prior to sleep [78]. The PAS is commonly
used in adults but has shown good internal
consistency in much younger populations (α = 0.85;
each subscale α = 0.75 [79]). PAS scores are able to
differentiate clinical from community samples and
correlate significantly with anxiety and sleep
measures.
(f ) Paediatric Daytime Sleepiness Scale (PDSS) - The
PDSS is an 8-item self-report questionnaire designed
to assess daytime sleepiness in children and
adolescents [80].
(g) Sleep Beliefs Scale (SBS) - The SBS is an 20-item
self-report questionnaire designed to assess general
beliefs about sleep, including the influence of
substances, diurnal behaviours and pre-sleep
activities and thoughts on sleep [81]. The SBS is
based on the Sleep Hygiene Awareness and Practice
Scale (SHAPS) [82, 83], designed for use in clinical
and non-clinical populations [84, 85]. The SBS has
three factors: (1) sleep-incompatible behaviours,
(2) sleep-wake cycle behaviours and (3) thoughts
and attitudes about sleep [81]. The total and
subscale scores have been shown to have acceptable
internal consistency in non-clinical samples (total
score α = 0.71, subscale α range = 0.47–.63) [81].
Objective measures
(a) Actigraphy. Objective sleep was assessed using
Actiwatch-64, Actiwatch-L and Actiwatch 2
(Mini-Mitter Company, Sun River, OR, USA)
wristwatch monitors of physical activity used to
assess sleep-wake patterns in normal environment
over extended periods of time. Actigraphy has
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been well validated and tolerated in adolescent
populations [86].
Medical history measure
(a) A medical history questionnaire used in previous
studies [87] was administered in interview form,
and includes items about chronic or current
illnesses, family history of cardiovascular disease,
substances consumed on the day, and measures of
height, weight and waist circumference.
Cardiovascular measures
(a) Blood Pressure: Blood pressure was measured
using a continuous finger blood pressure device
(Portapres, Model 2). This apparatus provides
continuous assessment of BP using finger cuffs. It
also provides an automated height adjustment
feature. Maximum (SBP) and minimum (DBP) BP
points are identified for each cardiac cycle using a
computer algorithm with the points being visually
checked and corrected where necessary. In addition
a brachial blood pressure measurement was taken
using standard automatic brachial blood pressure
monitor.
(b) Vagal Activity/Autonomic Balance: Heart rate
variability was derived from a three-lead
electrocardiograph (ECG). The ECG will be
recorded through Meditrace Ag/AgCl spot
electrodes. Electrodes were placed on subject’s
lower left and lower right rib cage and a third
on the right clavicular notch. The right rib cage
electrode served as the ground and the remaining
two as recording sites. During subsequent analyses R
waves were detected using an automated algorithm,
allowing IBI to be calculated by the program. The
detection of R waves were then visually checked and
edited where the automatic detection is incorrect.
Power spectrum analysis of the IBI data was
conducted to determine autonomic balance.
(c) Endothelial Dysfunction: Endothelial functioning
was assessed by measuring the hyperemic response
to a 5 min occlusion of the brachial artery. Brachial
artery occlusion was achieved using a standard
blood pressure cuff, while the vascular response to
occlusion release was be measured by Endo-PAT
2000 equipment (Itamar, Israel). All procedures
were non-invasive.
(d) Inflammatory markers: Saliva samples were
collected from participant to determine the level of
IL-1α, IL-1β, TNFα, IL-6, C-reactive protein, using
Bioplex assay kits and the Bioplex instrument.
Saliva was collected instead of serum as our
previous work has shown that levels of inflammatory
proteins correlate well in adolescents and importantly,
the sensitivity and detection of cytokines was found to
be greater in saliva [88]. Participants collected three
2 mL samples (upon awakening, during the afternoon
after school and before going to sleep) each day for
two consecutive days at their home, via passive drool.
Participants were instructed to avoid eating, drinking,
taking medications and brushing their teeth at least
30 min prior to collection. They were also instructed
to place samples in their home freezer immediately
after collection. Samples were returned on ice and
placed in -30 °C freezers until time of assay. All
samples were kept frozen from collection to time of
processing for bio-assay analysis.
Sample size requirements and power calculation
A power analysis was conducted prior to commence-
ment of the study in order to provide a guide to sample
size requirements. Recruitment was school-based using
a cluster sampling scheme to optimize the two-gate
screening method being employed (remembering, how-
ever, that the RCT is not cluster-based, because alloca-
tion is at the individual level). Calculations were based
on feasible differences in treatment effect at follow-up,
where attrition will be greatest. We initially estimated
power under assumptions of simple random sampling,
and then adjustment was made for the design effect ex-
ceeding 1 due to the cluster sampling design.
The treatment effect was estimated to result in group
differences of 0.45 SDs for continuous outcome mea-
sures and an odds ratio of 2.5 for case level depression,
based on preliminary published findings [89]. For
α = .05, 120 participants at follow-up was estimated to
provide 80 % power. Pre-post changes due to interven-
tion in the pilot data were significantly larger than
these conservative effect size estimates [48].
Based on our previous experience, we conservatively
estimated 10 % attrition from baseline to follow-up, im-
plying that 120/0.90 = 134 adolescents would need to be
randomly allocated into the two arms of the study (this
was close to the 144 individuals actually randomized).
We expected 60 % screening agreement, and 16 % to
meet screening cut-off criteria (this was also close to the
27 % who actually met screening criteria). It was conser-
vatively estimated that (i) 70 % meeting screening cri-
teria would also meet diagnostic interview criteria (86 %
actually did), and (ii) 50 % meeting diagnostic inclusion
would participate in the RCT (65 % actually did). The
estimated design effect [90] was 1.44 based on an aver-
age cluster-size of 9.275, a coefficient of variation for
cluster size of 0.25, and an intra-class correlation of 0.05
on continuous outcome measures. The final estimated
required sample size at baseline adjusted for design
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effect and attrition was 1.44 × 134 = 194 adolescents,
which corresponded to estimating need to screen at
194/9.275 = 21 schools. The final actual number of
schools screened was 23.
Statistical analysis
We plan to examine treatment group differences and
differential group changes from baseline to follow-up for
outcome measures in all 3 hypotheses using multilevel
modeling [91, 92] to account for any cluster sampling ef-
fects. Hypothesized mediating effects of sleep improve-
ment on the relationship between treatment condition
and outcomes will be assessed using bootstrap confi-
dence intervals [93]. Any recruitment bias between con-
senters and refusers after diagnostic screening, and any
differential attrition effects by comparing baseline char-
acteristics of drop-outs and continuing participants, will
be investigated using these models.
Discussion
There is great interest in the possibility that sleep is a
modifiable risk factor for the emergence of depression in
adolescence. This unique study will provide critical infor-
mation regarding the effectiveness of a brief sleep inter-
vention for preventing depression, improving wellbeing
and enhancing cardiac health in adolescents with anxiety
and sleep problems. Given the high prevalence of adoles-
cent depressive disorders, as well as the significant mor-
bidity and mortality associated with both depressive and
cardiac disease throughout the lifespan, the implications
of an effective intervention of this type for clinical practice
and public policy are potentially significant. Indeed, if the
intervention proves to be effective it can easily be dissemi-
nated to a wide range of clinical settings in primary care,
mental health, adolescent health and sleep medicine. The
intervention lends itself to flexible modes of delivery (e.g.,
non-specialist practitioners, group settings, school based,
internet and other e-health modes of delivery), further en-
hancing its translational potential.
Trial status
At submission of this article, Phases 1–4 had been
completed, such that 118 eligible participants in nine
parallel groups have completed the interventions and
pre/post assessments. One additional participant com-
pleted the SENSE Study control group because of a
scoring error at the screening phase, but did not meet
eligibility criteria, so will be excluded from future ana-
lyses. Two-year follow-up assessments began in June
2015 and will be completed by December 2016, as such,
the main outcomes of the study (preventative effects)
are yet to be assessed.
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